Johnson & JohnsonvsQ32 Bio

JNJ and QTTB stock compared: price, dividend, valuation and results, from SEC filings.

Johnson & Johnson (JNJ) has a market value of $644B and Q32 Bio (QTTB) $254M. Over the last year, with dividends, JNJ moved +36.6% and QTTB +271.9%. The P/E is 40.0 for JNJ and 7.9 for QTTB. Dividend yield: JNJ 1.98%, QTTB none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$644B

    QTTB$254M

    JNJ is 2,537 times QTTB

  • Revenue, 12 months

    JNJ$99.3B

    QTTB$54M

    JNJ is 1,849 times QTTB

  • Net income, 12 months

    JNJ$16.1B

    QTTB$32M

    JNJ is 499 times QTTB

  • Operating margin

    JNJ–

    QTTB31.5%

  • ROIC

    JNJ12.4%

    QTTB31.8%

    19.4 points apart

  • P/E

    JNJ40.0

    QTTB7.9

    JNJ is 5.1 times QTTB

  • Dividend yield

    JNJ2.0%

    QTTB0.0%

    2.0 points apart

  • 5-year return

    JNJ+89.1%

    QTTB-91.0%

    180.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+89.1%

QTTB-91.1%

010020020222023202420252026
Returns by period
PeriodJNJWith dividendsQTTBWith dividends
1 year since November 18, 2025+36.6%Price +33.6%+271.9%Price +271.9%
3 years since November 17, 2023+94.2%+24.8% a yearPrice +78.3%-15.9%-5.6% a yearPrice -15.9%
5 years since November 18, 2021+89.1%+13.6% a yearPrice +64.5%-91.0%-38.3% a yearPrice -91.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonQTTBQ32 Bio

Valuation

JNJQTTB
Valuation
Price$267.14$8.48
Market value$644B$254M
Enterprise value (EV)$671B–
P/E40.07.9
P/E, 5-year median21.9–
P/B7.90.9
EV/EBIT37.8–
Free cash flow yield3.2%–

Results and growth

JNJQTTB
Results and growth
Revenue, 12 months$99.3B$54M
Net income, 12 months$16.1B$32M
Free cash flow, 12 months$20.6B-$20M
Earnings per share, 12 months$6.59$1.08
Revenue growth, year on year6.1%–
Revenue growth a year, past+2.7%over 5 years+81.9%over 5 years
EPS growth a year, past+14.9%over 5 years–

Margins and returns on capital

JNJQTTB
Margins and returns on capital
Gross margin67.6%–
Operating margin–31.5%
Net margin16.2%55.5%
ROIC12.4%31.8%
ROE19.7%34.8%

Balance sheet

JNJQTTB
Balance sheet
Cash$17.2B$290M
Total debt$44.7B$8.6M
Net debt / EBITDA1.1-16.6
Interest cover18.0×–

Dividends and buybacks

JNJQTTB
Dividends and buybacks
Dividend yield2.0%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or QTTB

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Q32 Bio?

By market value, Johnson & Johnson ($644B) is about 2,537.0 times Q32 Bio ($254M), at today's prices.

How did JNJ and QTTB stock do over the last 5 years?

Since November 18, 2021, JNJ's price moved +64.5% and QTTB's -91.0%. With dividends: JNJ +89.1% (+13.6% a year), QTTB -91.0% (-38.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or QTTB?

The dividend yield at today's price is 1.98% for Johnson & Johnson and none for Q32 Bio. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and QTTB?

At today's price, the P/E is 40.0 for JNJ and 7.9 for QTTB. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Johnson & Johnson or Q32 Bio?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 55.5% for Q32 Bio, and the operating margin – and 31.5%. Revenue was $99.3B and $54M.

Which is the better investment, Johnson & Johnson or Q32 Bio?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.